| Tipoffs for Maine (New England) Newsletter for Tuesday November 14, 2023 ( 11 items ) |
|
Anti-clotting pill reduced stroke risk in adults with symptomless, irregular heart rhythm
DALLAS, Texas, Nov. 12 [Category: Health Care] -- The American Heart Association issued the following news release:
Research Highlights:
In a large study of adults with implanted heart devices that detected short, symptomless bouts of irregular heart rhythm, known as subclinical atrial fibrillation, those who took the anti-clotting medication apixaban were 37% less likely to have a stroke or blood clot compared to adults taking daily aspirin.
While the anti-clotting medication was linked with
more
DEA's National Prescription Drug Take Day Removes Almost 600,000 Pounds of Unneeded Prescription Medications Across the Country
BOSTON, Massachusetts, Nov. 13 -- The U.S. Department of Justice Drug Enforcement Administration's New England Division issued the following news release:
El Paso, Texas - On Oct. 28, 2023, the community once again emptied their medicine cabinets to help dispose of old, unwanted, and expired medications. Nationwide, DEA and its law enforcement partners collected 599,897 pounds of unneeded medications at 4,675 collection sites nationwide.
Locally, the El Paso Division collected 4,409 pounds fro
more
GEI Captures Phoenix Award for Conley Terminal's Berth 10 Project
BOSTON, Massachusetts, Nov. 14 -- GEI Consultants issued the following news release:
GEI Consultants captured a prestigious Phoenix Award for the firm's brownfields remediation work on Massachusetts Port Authority's (Massport's) Conley Terminal Modernization - Berth 10 project. Presented at the 2023 National Brownfields Training Conference, the Phoenix Awards recognize high quality brownfields projects and their achievements around the country.
The Conley Terminal Modernization - Berth 10 proj
more
Hartford Man Caught with Drugs and Ghost Gun in Bristol Sentenced to 30 Months in Federal Prison
BOSTON, Massachusetts, Nov. 13 -- The U.S. Department of Justice Drug Enforcement Administration's New England Division issued the following news release:
HARTFORD, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, announced that TRAEVAUGHNN MORRISON, 27, of Hartford, has been sentenced by U.S. District Judge Alvin W. Thompson in Hartford to 30 months of imprisonment, followed by four years of supervised release, for distributing fentanyl and crack while arm
more
Long Island Man Pleads Guilty to Conspiring to Distribute Fentanyl That Contributed to Two Overdose Deaths
BOSTON, Massachusetts, Nov. 13 -- The U.S. Department of Justice Drug Enforcement Administration's New England Division issued the following news release:
BROOKLYN, N.Y. - Earlier today, in federal court in Central Islip, Charles Carter, also known as "Chase," pleaded guilty to conspiring to distribute more than 40 grams of fentanyl. As part of his plea, Carter admitted that fentanyl that he sold contributed to the drug overdose deaths of two victims ("Victim-1" and "Victim-2") in 2020 and 2021
more
Northwest Arkansas Fentanyl Distributors Sentenced to Combined 52 Years in Federal Prison in Drug Overdose Death Cases
BOSTON, Massachusetts, Nov. 13 -- The U.S. Department of Justice Drug Enforcement Administration's New England Division issued the following news release:
An Arkansas man was sentenced Nov. 6 to 14 years in federal prison, without the possibility of parole, on one count of Possession of Fentanyl with the Intent to Distribute. The Honorable Judge Timothy L. Brooks presided over the sentencing hearing in the United States District Court in Fayetteville.
In early 2022, Agents with the Drug Enforc
more
Repeat Felon Sentenced to Over 13 Years for Drug Trafficking and Illegal Possession of Firearms and Glock Switches
BOSTON, Massachusetts, Nov. 13 -- The U.S. Department of Justice Drug Enforcement Administration's New England Division issued the following news release:
INDIANAPOLIS - Michael Gannon, Assistant Special Agent in Charge of Drug Enforcement Administration-Indianapolis, and U.S. Attorney Zachary A. Myers for the Southern District of Indiana announced that Phillip Bonds, 39, of Indianapolis, has been sentenced to 160 months in federal prison after pleading guilty to possession with intent to distr
more
Rutgers: Transfusing More Blood May Benefit Patients Who Have Had Heart Attack and Have Anemia
NEW BRUNSWICK, New Jersey, Nov. 13 (TNSres) -- Rutgers University issued the following on Nov. 11, 2023:
* * *
Rutgers physician heads international trial funded by the National Institutes of Health National Heart, Lung, and Blood Institute
* * *
By Jennifer Forbes Mullenhard
An international clinical trial led by physician Jeffrey L. Carson, distinguished professor of medicine at Rutgers Robert Wood Johnson Medical School, found that a liberal blood transfusion given to patients who have h
more
Two Indicted for Conspiracy Involving Manufacturing of Counterfeit Pills Containing Fentanyl
BOSTON, Massachusetts, Nov. 13 -- The U.S. Department of Justice Drug Enforcement Administration's New England Division issued the following news release:
Two North Shore men have been indicted by a federal grand jury in Boston for their alleged roles in a conspiracy involving the distribution and manufacturing of counterfeit pills containing fentanyl and other controlled substances.
Elmidio Crisostomo, 28, of Lynnfield, and David Depena, 30, of Lynn, were indicted on one count each of conspir
more
U.S. Department of Energy Invests Nearly $8.4 Million to Advance Grid-Enhancing Technologies
WASHINGTON, Nov. 14 -- The Department of Energy's Office of Electricity Delivery and Energy Reliability issued the following news on Nov. 13, 2023:
The U.S. Department of Energy (DOE) today selected four organizations to receive nearly $8.4 million to develop technologies that will improve grid reliability, optimize electricity infrastructure, and facilitate grid connection with renewable resources. DOE's Office of Electricity (OE) and Office of Energy Efficiency and Renewable Energy (EERE) are
more
VCU Health: Retatrutide 'Wiped Out' Fat in Liver of Obese Patients
RICHMOND, Virginia, Nov. 14 (TNSres) -- VCU Health, an academic medical center on the forefront of health care, providing patients with treatments and medical technology available, issued the following news release:
* * *
Potential drug to treat obesity may someday help some people avoid liver disease, VCU research says.
* * *
By A.J. Hostetler
More than 85% of obese participants with fatty liver disease in a clinical trial of the experimental drug retatrutide reduced their liver fat to the
more
|
Sign up to Receive this newsletter every day via email.
